Business Description
Cassava Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US14817C1071
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.51 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -112.6 | |||||
3-Year EPS without NRI Growth Rate | -109.3 | |||||
3-Year FCF Growth Rate | -112.1 | |||||
3-Year Book Growth Rate | 7.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.23 | |||||
9-Day RSI | 51.53 | |||||
14-Day RSI | 51.33 | |||||
6-1 Month Momentum % | -1.87 | |||||
12-1 Month Momentum % | -17.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 1.74 | |||||
Cash Ratio | 1.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -31.74 | |||||
ROA % | -26.75 | |||||
ROIC % | -276.5 | |||||
ROC (Joel Greenblatt) % | -449.79 | |||||
ROCE % | -65.84 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 11.95 | |||||
Price-to-Tangible-Book | 11.96 | |||||
EV-to-EBIT | -9.26 | |||||
EV-to-EBITDA | -9.4 | |||||
EV-to-Forward-Revenue | 4.02 | |||||
EV-to-FCF | -10.47 | |||||
Price-to-Net-Current-Asset-Value | 16.44 | |||||
Price-to-Net-Cash | 20.02 | |||||
Earnings Yield (Greenblatt) % | -10.8 | |||||
FCF Yield % | -8.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cassava Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -2.007 | ||
Beta | -2.56 | ||
Volatility % | 35.28 | ||
14-Day RSI | 51.33 | ||
14-Day ATR (€) | 0.773271 | ||
20-Day SMA (€) | 20.104 | ||
12-1 Month Momentum % | -17.37 | ||
52-Week Range (€) | 11.4 - 29.2 | ||
Shares Outstanding (Mil) | 47.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cassava Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cassava Sciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cassava Sciences Inc Frequently Asked Questions
What is Cassava Sciences Inc(STU:PX91)'s stock price today?
When is next earnings date of Cassava Sciences Inc(STU:PX91)?
Does Cassava Sciences Inc(STU:PX91) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |